Nature's Sunshine Products, Inc.

Nature's Sunshine Products, Inc. (NATR) Market Cap

Nature's Sunshine Products, Inc. has a market capitalization of $348M.

Price: $19.79

0.11 (0.56%)

Market Cap: 348.00M

NASDAQ · time unavailable

CEO: Kenneth G. Romanzi

Sector: Consumer Defensive

Industry: Packaged Foods

IPO Date: 2009-06-25

Website: https://www.naturessunshine.com

Nature's Sunshine Products, Inc. (NATR) - Company Information

Market Cap: 348.00M|Sector: Consumer Defensive

Company Profile

Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.

Analyst Sentiment

92%
Strong Buy

From 2 Active Polls

1Y Forecast: $37.00

▲ +87.0% Potential Upside

Consensus Target Metrics

Low Bound

$37

Median

$37

High Bound

$37

Average

$37

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$37.00
▲ +86.96% Upside
Low Target
$37.00
87% Risk
Median Target
$37.00
87% Mid
High Target
$37.00
87% Max
Consensus
Buy
2 / 4 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)348420378274272232271252280
Enterprise Value ($M)283355303192207160200189226
Price to Earnings Ratio (P/E)17.4320.5322.9912.8312.7612.22-210.9814.5051.84
Price/Earnings-to-Growth Ratio (PEG)1.089.62-67.363.94
Price to Sales Ratio (P/S)0.713.423.052.132.372.052.292.202.53
Price to Book Ratio (P/B)2.082.522.341.711.731.441.741.611.86
Price to Free Cash Flow Ratio (P/FCF)15.12-97.1749.9516.3091.05154.7727.1231.98-136.71
Enterprise Value to Sales (EV/Sales)2.892.441.501.801.421.701.652.05
Enterprise Value to EBITDA (EV/EBITDA)6.3531.1234.3214.5718.6615.0928.4221.3924.78
Debt to Equity Ratio-1.460.130.120.090.100.090.090.100.10

NATR Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$19.79
Intrinsic Value$19.77
Market Alignment
Overvalued by 0.1%relative to calculated intrinsic value
9.00%
Exp: 5%5%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.02B
Perpetuity TV Value$0.43B
Discounted TV (PV)$0.18B
TV Weighting %60.3%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 NATURES SUNSHINE PRODUCTS INC (NATR) — Investment Overview

🧩 Business Model Overview

Nature’s Sunshine Products operates a dietary supplement and personal wellness business built around (1) proprietary and third-party sourced products, (2) manufacturing and quality systems, and (3) distribution through independent channels. The company’s model typically monetizes wellness demand by selling products via a network that supports customer acquisition, repeat purchasing, and education around usage.

The economic engine is a blend of product-led demand and distributor-led selling: product availability and consistency underpin repeat orders, while the distributor/customer relationship creates durability in buying patterns. Manufacturing and sourcing capabilities influence gross margins and product availability, while compliance and quality systems influence brand credibility and regulatory outcomes.

💰 Revenue Streams & Monetisation Model

Revenue is primarily generated from the sale of nutritional supplements and related wellness products. Monetisation is less about one-off transactions and more about repeat purchasing cycles, supported by distributor channels and established customer purchasing habits.

Key margin drivers include:

  • Gross margin mix: product and ingredient mix, manufacturing efficiency, and inbound logistics/inputs.
  • Channel efficiency: marketing spend effectiveness and distributor incentive costs as a percentage of sales.
  • Inventory management: working capital discipline, obsolescence risk, and product availability.

🧠 Competitive Advantages & Market Positioning

NATR’s moat is best characterized as a distribution-network advantage with moderate stickiness, reinforced by quality and formulation capability.

Network effects / distribution leverage: In direct-to-consumer and independent sales models, a larger and more active distributor base can improve customer reach and replenishment frequency. New distributors often benefit from established training materials, buying programs, and product credibility, which can support ongoing sales productivity.

Switching costs (moderate): Customers in supplements face lower formal switching friction than in software, but switching costs become meaningful through habitual usage, perceived product efficacy, and distributor familiarity. This favors repeat purchasing when product quality and availability remain consistent.

Cost/quality scale: Manufacturing systems, supplier qualification, and quality controls can create a structural advantage versus smaller peers that struggle with consistency, compliance execution, and unit economics.

  • Herbalife (direct selling wellness): emphasis on global brand-led demand and broad product portfolio scale.
  • Amway / Nutrilite (direct selling nutrition): strong distribution scale and long-running franchise-like channel structure.
  • Nu Skin (direct selling wellness/beauty): category overlap with supplement and wellness demand, but different product focus and channel economics.

Compared with these rivals, NATR’s differentiating profile is rooted in its product and formulation approach paired with channel execution, rather than primarily competing on mega-scale brand sponsorship or advertising intensity.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth should be supported by structural demand for preventive wellness and functional nutrition. Core drivers include:

  • Demographic tailwinds: aging populations and sustained emphasis on healthy aging increase demand for supplements and routine wellness consumption.
  • Shift toward functional ingredients: ongoing consumer preference for targeted benefits (e.g., immune support, digestive health, energy/metabolism support) expands product category depth.
  • Channel expansion in underpenetrated markets: direct and distributor-led models can extend reach where traditional retail distribution is less efficient.
  • Product portfolio optimization: better mix from higher-margin offerings and improved replenishment economics can drive profitability even without extreme top-line growth.
  • Operational leverage: manufacturing consistency, purchasing discipline, and marketing efficiency can improve unit economics as scale stabilizes.

⚠ Risk Factors to Monitor

  • Regulatory and compliance risk: dietary supplement rules and enforcement vary by jurisdiction; missteps on labeling or claims can lead to restrictions, penalties, or product discontinuations.
  • Ingredient supply and quality volatility: input price swings, contamination risk, or supplier changes can pressure gross margins and force inventory write-downs.
  • Channel concentration and incentive dynamics: direct selling performance depends on distributor productivity and retention; incentive plan changes or distributor attrition can impact sales velocity.
  • Competitive pressure: larger peers with distribution scale and marketing resources can compress margins or increase customer acquisition costs.
  • Reputational risk: supplement businesses rely on trust; adverse publicity around efficacy, sourcing, or quality can have prolonged effects.

📊 Valuation & Market View

The market typically values supplement and wellness companies on a blend of price-to-sales (P/S) for growth and EV/EBITDA or earnings multiples for durability of margins and cash conversion. For NATR specifically, the valuation narrative tends to be driven by:

  • Gross margin sustainability driven by mix and manufacturing efficiency.
  • Operating leverage from improving marketing effectiveness and distributor productivity.
  • Cash flow quality reflected through working capital discipline and lower inventory drag.
  • Revenue quality such as repeat purchase behavior and healthy channel engagement.

Multiple expansion is usually less about accounting metrics and more about credible visibility into sustained margin and channel retention.

🔍 Investment Takeaway

NATURES SUNSHINE PRODUCTS presents a long-term thesis centered on distribution-driven stickiness and operational execution in dietary supplements. The investment case rests on whether the company can sustain product quality and channel productivity while managing regulatory and input risks—conditions that determine margin resilience and the durability of repeat purchasing economics.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for NATR.

marketbeat.com2026-05-08

Nature's Sunshine Products Q1 Earnings Call Highlights

Nature's Sunshine Products NASDAQ: NATR reported what management called a “very strong” start to 2026, highlighting first-quarter sales growth of 9% and adjusted EBITDA growth of 33% as the company continued to push deeper into digital channels and subscription programs while expanding its consultant base globally.

seekingalpha.com2026-05-07

Nature's Sunshine Products, Inc. (NATR) Q1 2026 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NATR) Q1 2026 Earnings Call Transcript

globenewswire.com2026-05-07

Nature's Sunshine Reports Strong First Quarter 2026 Results

Net Sales up 9% to $122.9 million, GAAP EPS up 16% to $0.29Adjusted EBITDA up 33% to $14.6 million LEHI, Utah, May 07, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) ("Nature's Sunshine" and/or the "Company"), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Summary vs.

globenewswire.com2026-04-30

Nature's Sunshine Appoints John Hnanicek as Chief Technology Officer

Experienced Technology and Digital Transformation Leader to Advance Company's Global Digital Strategy Experienced Technology and Digital Transformation Leader to Advance Company's Global Digital Strategy

globenewswire.com2026-04-23

Nature's Sunshine Sets First Quarter 2026 Conference Call for Thursday, May 7, 2026, at 5:00 p.m. ET

LEHI, Utah, April 23, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine” and/or the “Company”), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, will conduct a conference call on Thursday, May 7, 2026, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the first quarter ended March 31, 2026. The Company will report its financial results in a press release prior to the conference call.

seekingalpha.com2026-03-17

Nature's Sunshine May Perform Better Than Expected (Rating Upgrade)

Nature's Sunshine is upgraded to Buy, driven by robust DTC growth and effective influencer marketing. NATR exceeded 2025 guidance with $480.1M revenue and $49.4M adjusted EBITDA, signaling operational outperformance. Guidance for 2026 targets $500–$515M revenue and $50–$54M EBITDA, supporting a $37.99 price target—56% above current levels.

seekingalpha.com2026-03-11

Nature's Sunshine Products: The Rally May Not Be Over

Nature's Sunshine Products delivered Q4 results and 2026 guidance that exceeded analyst expectations, driving a post-market stock surge. NATR's revenue, profits, and adjusted profits all grew year-over-year, with notable strength in Europe and North America and robust cash holdings of $93.9 million. Management guides for 2026 revenue of $500–515 million and EBITDA of $50–54 million, with a long-term vision to reach $1 billion in revenue.

seekingalpha.com2026-03-10

Nature's Sunshine Products, Inc. (NATR) Q4 2025 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NATR) Q4 2025 Earnings Call Transcript

globenewswire.com2026-03-10

Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2025 Financial Results

LEHI, Utah, March 10, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine” and/or the “Company”), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2025.

247wallst.com2026-03-10

Wall Street Lifts Targets on Five Below, Ulta Beauty and Nature's Sunshine Ahead of Key Earnings Reports

Three consumer stocks are drawing fresh analyst attention this week as earnings season approaches.

globenewswire.com2026-02-24

Nature's Sunshine Sets Fourth Quarter 2025 Conference Call for Tuesday, March 10, 2026, at 5:00 p.m. ET

LEHI, Utah, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine”) (the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Tuesday, March 10, 2026, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its financial results in a press release prior to the conference call.

defenseworld.net2026-02-23

Nature’s Sunshine Products, Inc. $NATR Shares Purchased by Hillsdale Investment Management Inc.

Hillsdale Investment Management Inc. boosted its position in shares of Nature's Sunshine Products, Inc. (NASDAQ: NATR) by 107.9% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 170,804 shares of the company's stock after acquiring an additional 88,657 shares during the period.

defenseworld.net2026-02-19

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Short Interest Update

Nature's Sunshine Products, Inc. (NASDAQ: NATR - Get Free Report) was the target of a large increase in short interest in January. As of January 30th, there was short interest totaling 194,850 shares, an increase of 21.7% from the January 15th total of 160,148 shares. Currently, 1.2% of the shares of the stock are sold short.

seekingalpha.com2026-01-29

Best Staples Stocks As Consumer Confidence Hits Multi-Year Low

Consumer confidence has dipped to multi-year lows, yet the coming fiscal stimulus could support consumer spending on essentials. While macro conditions remain mixed, staples' relative stability and essential nature make them compelling considerations for diversified portfolios. Investors looking for defensive exposure can consider opportunities not just in large cap staple giants, but in niche and value-oriented names poised to benefit from macro trends.

globenewswire.com2025-12-15

Euromonitor International Names Synergy Pro-Argi-9+ the World's #1 L-Arginine Supplement

LEHI, Utah, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Synergy Worldwide, a division of Nature's Sunshine Products, today announced that Euromonitor International has named Pro-Argi-9+ the world's #1 l-arginine supplement,* reinforcing the product's growing global momentum and Synergy's leadership in the health and wellness space.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"NATR reported Q1’26 revenue of $122.9M and net income of $5.12M (EPS $0.29). Revenue rose +8.6% YoY (from $113.2M in Q1’25) and was roughly flat QoQ versus $123.8M in Q4’25 (-0.7%). Net income increased +7.8% YoY (from $4.75M) and +24.6% QoQ (from $4.11M). Profitability improved on a quarterly basis: gross margin expanded to ~73.2% in Q1’26 from ~61.3% in Q4’25, while net margin rose to 4.16% from 3.32% (Q4’25). Over the full 4-quarter trend, net margin remains generally solid (~3.3%–4.6%), with the most favorable gross margin profile in Q1’26 and Q3/Q2’25. Operating income of $9.55M translated to an operating margin of 7.77% in Q1’26. Cash flow weakened in Q1’26: operating cash flow was -$1.85M and free cash flow was -$4.33M, versus +$7.56M FCF in Q4’25. Liquidity remains strong with cash of $87.6M and equity of $166.9M; leverage is low with net debt still negative (net cash position). Total shareholder returns look strong: the stock is up +130.1% over 1 year, suggesting strong capital appreciation momentum (dividend/share buybacks are present, but no dividends were paid)."

Revenue Growth

Positive

Q1’26 revenue was $122.9M: +8.6% YoY, -0.7% QoQ (vs. $123.8M in Q4’25). Growth is positive YoY but not accelerating QoQ.

Profitability

Strong

Net margin improved to 4.16% in Q1’26 from 3.32% in Q4’25 and is slightly higher YoY (vs. ~4.19% in Q1’25). Gross margin jumped to ~73.2% from ~61.3% QoQ.

Cash Flow Quality

Caution

Q1’26 operating cash flow was -$1.85M and free cash flow -$4.33M, a sharp QoQ decline from Q4’25 FCF of +$7.56M. Net income remains positive, but cash conversion deteriorated.

Leverage & Balance Sheet

Strong

Balance sheet is resilient: total assets ~$261.5M and equity ~$166.9M. Net debt remains negative (net cash) at about -$65.1M, indicating low leverage risk.

Shareholder Returns

Excellent

1-year price change is +130.1% (>20%), strongly boosting total return. No dividends paid were shown; buybacks occurred (e.g., -$0.5M repurchase in Q1’26).

Analyst Sentiment & Valuation

Positive

Market price $27.34 versus consensus target ~$19.5 implies the stock is trading above Street expectations, which can cap upside despite strong momentum.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

NATR delivered a strong Q1 2026: net sales of $122.9M (+9% YoY; +7% ex-FX) and adjusted EBITDA up 33% to $14.6M, supported by faster digital growth and improved profitability. Gross margin expanded 116 bps to 73.2%, aided by logistics renegotiations, better manufacturing conversion/efficiency, sourcing improvements, disciplined pricing, and favorable mix. Digital momentum was a clear operational lever: North America digital sales grew 42% and new digital customers rose 60%, while Autoship accounted for 48% of digital website sales—reinforcing the management thesis that subscription increases retention and lifetime value. In Asia, Autoship adoption drove China’s turnaround (>25% of revenue) and field activation supported Korea/Japan after the Lemara skincare launch. Management reiterated 2026 guidance (net sales $500M–$515M; adjusted EBITDA $50M–$54M) but tempered EBITDA growth with a Q2–Q3 investment ramp in technology/automation and a cautious stance on Iran-driven demand/cost uncertainty. No debt and $87.6M cash provide flexibility; buybacks were modest.

AI IconGrowth Catalysts

  • Digital business growth: digital sales up 42% YoY in North America; new digital customers up 60% YoY; social commerce grew triple digits YoY (still small).
  • Subscription Autoship acceleration: in North America, Autoship drove retention/frequency; Autoship accounted for 48% of digital website sales; in China, Autoship rose from zero a year ago to >25% of revenue today.
  • Direct selling/consultant expansion: healthy increase in active consultants across the globe supporting growth across regions.
  • Improved product availability in Europe: Eastern Europe sales up 11% local currency driven by better in-stock levels for high-demand products.

Business Development

  • Partnership emphasis is primarily via independent consultants (global “army” of consultants) as distribution partners; no external named vendors/customers stated in the transcript.
  • Distribution/market initiatives: explore distribution in select U.S. brick-and-mortar retail channels (no retailer names provided).
  • Partnership-like channel via Asia sales system for pan-Asian product launch (Korea/Japan/Taiwan coordinated).

AI IconFinancial Highlights

  • Net sales: $122.9M, +9% YoY (or +7% excluding FX), stated as strongest first quarter in company history and third largest quarter ever.
  • EBITDA/Profitability: Adjusted EBITDA +33% to $14.6M on revenue growth and gross margin improvement.
  • Gross margin: +116 bps to 73.2% (from 72.1% YoY), driven by logistics renegotiations, manufacturing efficiency/cost conversion, improved sourcing, more disciplined pricing, and other cost-saving measures.
  • SG&A: $43.5M vs $40.6M prior year; SG&A as % of sales 35.4% vs 35.8% YoY; increased costs attributed to variable costs for higher sales and compensation.
  • Operating income: +53% to $9.5M (7.8% of net sales) vs $6.2M (5.4% of net sales) prior year.
  • EPS: GAAP net income attributable to common shareholders $5.1M, $0.28 diluted EPS vs $4.7M, $0.25 diluted EPS prior year.
  • Volume incentives as % of net sales: 30.0% vs 30.8% prior year (decline attributed to strong digital mix and market mix changes).
  • Capital structure: zero debt; cash and cash equivalents $87.6M.
  • Repurchases: 20k shares repurchased for ~$0.5M ($24.54/share); $16.9M remaining on repurchase program.
  • Guidance caution: 2026 adjusted EBITDA guidance incorporates cautious stance on potential Iran conflict impact on demand and cost.

AI IconCapital Funding

  • Share repurchases: ~$0.5M in Q1 (20k shares); $16.9M remaining under the repurchase program.
  • Debt/cash: zero debt; cash and cash equivalents $87.6M.
  • Operating cash flow: net cash used by operating activities of $1.8M vs cash provided of $2.6M in prior-year period.
  • Inventory: $67.1M at quarter end, down $1.2M vs Q4 last year; company expects moderate inventory increase during 2026 for in-stock levels.

AI IconStrategy & Ops

  • Digital transformation continues: mid- to high-single-digit revenue growth in North America expected through 2026 tied to digital momentum and Autoship adoption.
  • Automation/efficiency: plan to invest in automation to drive efficiencies; excess capacity in manufacturing facility expected to improve variable margins with volume growth.
  • Technology infrastructure spend: Q2 and Q3 ramps for investments (technology, customer acquisition, geographic expansion, product innovation) temporarily reducing EBITDA growth rate from typical historical levels.
  • Consultant enablement: launched an app enabling independent consultants to run their entire business by phone; more digital enablement planned.

AI IconMarket Outlook

  • Full-year 2026 net sales guidance: $500M–$515M (vs $480M for 2025), implying +4% to +7% YoY.
  • Full-year 2026 adjusted EBITDA guidance: $50M–$54M (+ up to 19% YoY), with Iran conflict risk incorporated.
  • North America outlook: mid- to high-single-digit revenue growth throughout 2026.
  • Europe outlook: continued mid-single-digit growth for remainder of 2026.
  • China/near-term caution: 40% Q1 growth unlikely to be repeated in the coming quarter.

AI IconRisks & Headwinds

  • Geopolitical tensions in Iran: monitored for potential inflation impact and short-term consumer buying pattern effects; company guided with cautious stance for demand and cost impacts.
  • China normalization risk: >25% Autoship and strong drivers produced 40% Q1 growth, but management expects that level is unlikely to repeat next quarter.
  • Execution risk from investment ramp: technology/strategic investments ramp in Q2–Q3 expected to temporarily reduce EBITDA growth rate to single digits.

Q&A: Analyst Interest

  • Topic: 15% long-term EBITDA margin building blocks and relative contributions (gross margin vs incentives vs SG&A). Management’s detailed response: Management framed the target as a scale-driven outcome, with “three blocks.” They said they are “a little over 10%” today and to reach 15%: ~1 point from gross margin, ~2 points from lowering volume incentives via digital mix, and ~2 points from SG&A leverage through growth (not headcount cuts).
  • Topic: New CTO appointment and implications for digital growth, AI, and ERP modernization. Management’s detailed response: Management said the CTO hire is “crucially important,” spanning base infrastructure and AI. They cited ERP end-of-life in 5–6 years (Oracle) requiring a “next step,” plus accelerating digital growth, direct-to-consumer capabilities, and digitally enabling consultants via new tools such as a phone-based business app; investments drove reduced EBITDA growth temporarily.
  • Topic: Brand/product drivers by region and how new products will be rolled out in 2026. Management’s detailed response: Management differentiated brands: Nature’s Sunshine Products drives U.S., North America, Latin America, Europe, and China; Synergy drives the rest of APAC (Korea, Taiwan, Japan, Southeast Asia). They avoided specifying near-term products but described a “smattering” rollout and a novel pan-Asian launch in Korea/Japan/Taiwan with the same formulation and timing.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the NATR Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for NATR.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (NATR)

© 2026 Stock Market Info — Nature's Sunshine Products, Inc. (NATR) Financial Profile